Stockholm - Delayed Quote SEK

Perpetua Medical AB (publ) (PERP-B.ST)

4.2900
0.0000
(0.00%)
At close: May 22 at 5:15:11 PM GMT+2

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
NameTitlePayExercisedYear Born
Mr. Anders Hedlund Refounder, CEO & Director -- -- 1985
Mr. Hans Dahlin Founder & Advisor to CEO -- -- --
Ms. Camilla Lonn Chief Financial Officer -- -- 1972

Perpetua Medical AB (publ)

Ekeby bruk 2H
Uppsala, 752 63
Sweden
46 18 50 01 01 https://perpetuamedical.se
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
3

Description

Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. The company offers DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024. Perpetua Medical AB (publ) was incorporated in 2007 and is headquartered in Uppsala, Sweden. Perpetua Medical AB (publ) operates as a subsidiary of Nolsterby Invest AB.

Corporate Governance

Perpetua Medical AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

April 16, 2021 at 12:00 AM UTC

Ex-Dividend Date